Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors

被引：6

作者：

McKittrick, Brian A. ^{[1
]}

Caldwell, John P. ^{[1
]}

Bara, Thomas ^{[1
]}

Boykow, George ^{[3
]}

Chintala, Madhu ^{[3
]}

Clader, John ^{[1
]}

Czarniecki, Michael ^{[1
]}

Courneya, Brandy ^{[6
]}

Duffy, Ruth ^{[3
]}

Fleming, Linda

Giessert, Rachel ^{[6
]}

Greenlee, William J. ^{[1
]}

Heap, Charles

Hong, Liwu ^{[1
]}

Huang, Ying ^{[1
]}

Iserloh, Ulrich ^{[1
]}

Josien, Hubert ^{[1
]}

Khan, Tanweer ^{[1
]}

Korfmacher, Walter ^{[4
]}

Liang, Xian ^{[1
]}

Mazzola, Robert ^{[1
]}

Mitra, Soumya ^{[6
]}

Moore, Kristina ^{[3
]}

Orth, Peter ^{[2
]}

Rajagopalan, Murali ^{[1
]}

Roy, Sudipta ^{[6
]}

Sakwa, Samuel ^{[6
]}

Strickland, Corey ^{[2
]}

Vaccaro, Henry ^{[1
]}

Voigt, Johannes ^{[2
]}

Wang, Hongwu ^{[2
]}

Wong, Jesse ^{[1
]}

Zhang, Rumin ^{[5
]}

Zych, Andrew ^{[6
]}

机构：

[1] Merck Res Labs, Discovery Chem, Kenilworth, NJ 07033 USA

[2] Merck Res Labs, Struct Chem, Kenilworth, NJ 07033 USA

[3] Merck Res Labs, Cardiovasc Pharmacol, Kenilworth, NJ 07033 USA

[4] Merck Res Labs, Pharmacokinet Pharmacodynam & Metab, Kenilworth, NJ 07033 USA

[5] Merck Res Labs, Biochem & Biophys, Kenilworth, NJ 07033 USA

[6] Albany Mol Res Inc, Dept Med Chem, Albany, NY 12203 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 07期

关键词：

Renin inhibitors; BACE1; Hypertension; Structure-based drug design; Enzyme inhibitors; STRUCTURE-BASED DESIGN; BACE1; INHIBITORS; TRANSGENIC RATS; DRUG DISCOVERY; HYPERTENSION; ALISKIREN; POTENT; MANAGEMENT; VTP-27999; PART;

D O I：

10.1016/j.bmcl.2015.02.003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The development of renin inhibitors with favorable oral pharmacokinetic profiles has been a longstanding challenge for the pharmaceutical industry. As part of our work to identify inhibitors of BACE1, we have previously developed iminopyrimidinones as a novel pharmacophore for aspartyl protease inhibition. In this letter we describe how we modified substitution around this pharmacophore to develop a potent, selective and orally active renin inhibitor. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：1592 / 1596

页数：5

共 50 条

[21] Discovery of novel orally bioavailable renin inhibitors by structure based drug design
Edmunds, Jeremy J.
Belliotti, Thomas
Bryant, John
Cai, Cuiman
Cheng, Xue Min
Ciske, Fred L.
Cody, Wayne L.
Collard, Wendy
Downing, Dennis M.
Erasga, Noe
Ferreira, Suzie
Hall, Eric
Holsworth, Daniel D.
Jalaie, Mehran
Kasani, Aparna
Kaufman, Michael
Lee, Chitase
Li, Tingsheng
Maiti, Samarendra
McConnell, Patrick
Mennen, Ken
Ostroski, Robert
Powell, Noel A.
Quinn, John, III
Rahim, Mohammad
Ryan, Michael
Stier, Michael A.
Subedi, Rajandra
Van Huis, Chad
Zhang, Erli
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[22] MACROCYCLIC RENIN INHIBITORS - SYNTHESIS OF A SUBNANOMOLAR, ORALLY-ACTIVE CYSTEINE DERIVED INHIBITOR
YANG, LH
WEBER, AE
GREENLEE, WJ
PATCHETT, AA
TETRAHEDRON LETTERS, 1993, 34 (44) : 7035 - 7038
[23] DESIGN AND SYNTHESIS OF POTENT, SELECTIVE, AND ORALLY ACTIVE FLUORINE-CONTAINING RENIN INHIBITORS
DOHERTY, AM
SIRCAR, I
KORNBERG, BE
QUIN, J
WINTERS, RT
KALTENBRONN, JS
TAYLOR, MD
BATLEY, BL
RAPUNDALO, SR
RYAN, MJ
PAINCHAUD, CA
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) : 2 - 14
[24] Effects of multiple dosing with orally active renin inhibitors in conscious, unrestrained marmosets.
Fogal, SE
Miner, E
Madwed, J
Desai, S
Thibeault, D
Simoneau, B
Jung, GL
Lavallee, P
Poupart, MA
Anderson, PC
Winquist, RJ
Panzenbeck, MJ
FASEB JOURNAL, 1996, 10 (03): : 4032 - 4032
[25] Novel orally active, dibenzampinone-based γ-secretase inhibitors
Peters, Jens-Uwe
Galley, Guido
Jacobsen, Helmut
Czech, Christian
David-Pierson, Pascale
Kitas, Eric A.
Ozmen, Laurence
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5918 - 5923
[26] NOVEL ORALLY ACTIVE INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME
KARANEWSKY, DS
BADIA, MC
CUSHMAN, DW
DEFORRES, JM
DUGGAN, ME
LOOTS, MJ
PERRI, MG
PETRILLO, EW
POWELL, JR
RYONO, DE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 8 - MEDI
[27] Discovery of novel and orally active inhibitors of lck kinase.
Goldberg, D
Butz, T
Cardozo, M
Eckner, R
Hammach, A
Huang, J
Jakes, S
Kapadia, S
Lukas, S
Morwick, T
Moss, N
Panzenbeck, M
Patel, U
Peet, G
Peterson, J
Prokopowicz, A
Snow, RJ
Takahashi, H
Tan, J
Tschantz, M
Wang, XJ
Xiang, P
Zinter, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U643 - U643
[28] Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors
Wang, Yuanyuan
Ma, Hao
Huang, Jiaxuan
Yao, Zhengguang
Yu, Jianqiang
Zhang, Wannian
Zhang, Lichao
Wang, Zhibin
Zhuang, Chunlin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
[29] ANTIHYPERTENSIVE EFFICACY OF PD-134672 - A NOVEL ORALLY ACTIVE RENIN INHIBITOR
RYAN, MJ
BATLEY, BL
HICKS, GW
PAINCHAUD, CA
RAPUNDALO, ST
TAYLOR, DG
FASEB JOURNAL, 1991, 5 (06): : A1575 - A1575
[30] Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor
Imaeda, Yasuhiro
Tokuhara, Hidekazu
Fukase, Yoshiyuki
Kanagawa, Ray
Kajimoto, Yumiko
Kusumoto, Keiji
Kondo, Mitsuyo
Snell, Gyorgy
Behnke, Craig A.
Kuroita, Takanobu
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 933 - 938

← 1 2 3 4 5 →